Table 3.

Multivariate analysis of prognostic variables

DFSOS
VariableComparisonHR (95% CI)PHR (95% CI)P
SubtypeBasal vs. Luminal A1.57 (0.75–3.29)0.022.19 (0.91–5.26)0.02
Her2+ vs. Luminal A2.25 (1.29–3.90)2.74 (1.39–5.40)
Luminal B vs. Luminal A1.98 (1.16–3.39)2.40 (1.25–4.63)
TreatmentTamoxifen vs. placebo0.58 (0.41–0.82)0.0020.68 (0.45–1.02)0.06
ERPositive vs. negative0.82 (0.53–1.28)0.380.58 (0.35–0.97)0.04
Nodal status1–3 vs. negative1.97 (1.20–3.22)0.021.61 (0.92–2.81)0.17
>3 vs. negative1.97 (1.12–3.48)1.78 (0.94–3.37)
Tumor sizeT stage 1 vs. >10.64 (0.44–0.92)0.020.62 (0.40–0.96)0.03
Tumor grade1 vs. 2 vs. 30.96 (0.71–1.31)0.810.83 (0.58–1.19)0.30